carboplatin,paclitaxel,nivolumab
bms
['lcsm,(-blcsm)', 'nadim']
poster 169: predicting pcr with neo-adjuvant chemoio in iiia resectable disease. based on nadim dataset. given huge benefit pcr patient group has with chemoio, would be valuable if we could, ?taking chemort approach if pcr not likely. #lcsm #asco22 
Thoracic medical oncologist | Consultant @ChelwestFT | Vice Chair @BTOGorg | Skier, when snow permits.